![]() Dynavax Technologies Dynavax Technologies Corporation is a biopharmaceutical company discovering and developing novel products to prevent and treat infectious, autoimmune and inflammatory diseases, and the treatment of cancer. | Livzon Pharmaceutical Group Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products. | YiChang HEC ChangJiang Pharmaceutical YiChang HEC ChangJiang Pharmaceutical is a company that develops, manufactures, and sells pharmaceutical products. | |
Founding Date | Founding Date 1996 | Founding Date 1985 | Founding Date 2001 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Emeryville, US HQ Düsseldorf, DE Berkeley, US | Locations Zhuhai, CN HQ Chengdu, CN Qingyuan, CN Shanghai, CN Shaoguan, CN Shenzhen, CN Zhuhai, CN | Locations HQ |
Employees | Employees 24946% increase | Employees 9,067 | Employees 4,595 |
Valuation ($) | Valuation ($) 1.5 b | Valuation ($) 4.2 b | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) $277.2m (FY, 2024) | Revenue (est.) ¥11.7b (FY, 2025) | Revenue (est.) ¥3.7b (FY, 2024) |
Cost of goods | Cost of goods N/A | Cost of goods ¥4.1b (FY, 2025) | Cost of goods ¥533.6m (FY, 2024) |
Gross profit | Gross profit N/A | Gross profit ¥7.8b (FY, 2025) | Gross profit ¥3.2b (FY, 2024) |
Net income | Net income $27.3m (FY, 2024) | Net income ¥2.4b (FY, 2025) | Net income ¥482.7m (FY, 2024) |
Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.
View companyYiChang HEC ChangJiang Pharmaceutical is a company that develops, manufactures, and sells pharmaceutical products.
View company